ISTOCK, JUANMONINO
Traitorous Tumor Cells Kill Their Own Kind
Traitorous Tumor Cells Kill Their Own Kind
Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.
Traitorous Tumor Cells Kill Their Own Kind
Traitorous Tumor Cells Kill Their Own Kind

Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.

Researchers plan to turn cancer cells into defectors, engineering them to kill the tumors from whence they came, and have tested the approach in mice.

cancer, drug development, biotech, business, regulation
Supreme Court Nominee Draws Concern from Environmentalists
Supreme Court Nominee Draws Concern from Environmentalists
Catherine Offord | Jul 10, 2018
President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.
Natural Killer Cells Prove Effective as a CAR Therapy in Mice
Natural Killer Cells Prove Effective as a CAR Therapy in Mice
Katarina Zimmer | Jul 6, 2018
Stem-cell–derived natural killer cells engineered in a similar way to CAR-T cells may pave the way to “off the shelf” cancer therapies that aren’t patient-specific.
Opinion: Deductive Science Is Needed for Public Health
Opinion: Deductive Science Is Needed for Public Health
Giuseppe Carruba | Jun 27, 2018
Big data and empirical approaches to understanding diseases provide a limited picture of pathogenesis.
Artificial Intelligence to Boost Liquid Biopsies
Artificial Intelligence to Boost Liquid Biopsies
Claire Asher | Jun 26, 2018
Machine-learning algorithms tuned to detecting cancer DNA in the blood could pave the way for personalized cancer care.
FDA Approves First Marijuana-Derived Drug
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
CRISPR Efficiency Tied to Cancer-Causing Process
CRISPR Efficiency Tied to Cancer-Causing Process
Kerry Grens | Jun 11, 2018
Two studies find the genome-editing technique works best when cells have a faulty DNA-damage response that’s frequently present in cancers.  
EPA to Limit Assessments of Toxic Chemical Risks
EPA to Limit Assessments of Toxic Chemical Risks
Ashley Yeager | Jun 8, 2018
Reducing the evaluation to only direct contact, rather than including environmental exposures, could leave damaging substances on the market, critics say.
Researchers React to Microsoft’s Acquisition of GitHub
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
Image of the Day: New Kids on the Block
Image of the Day: New Kids on the Block
Sukanya Charuchandra | Jun 7, 2018
Researchers discover that a layer of human breast tissue is not one but two distinct cell types.